Title: Sevoflurane inhibits cholangiocarcinoma via Wnt/#-catenin Signaling pathway
Version: 1 Date: 13 Apr 2023
Reviewer's report:
Chen et al. explored the effects of sevoflurane on CCA proliferation and apoptosis through
the Wnt/#-catenin signaling pathway. This study suggests a potential role for sevoflurane in
the treatment of CCA. The authors wrote in good English, which was easy for the readers to
understand. However, if possible, I suggest the authors to add the expression of key proteins
downstream of the Wnt/#-catenin pathway, such as GSK3#, C-Myc and CyclingD1 to enhance
the reliability of the experiment.
Title: Sevoflurane inhibits cholangiocarcinoma via Wnt/#-catenin Signaling pathway
Version: 1 Date: 13 Apr 2023
Reviewer's report:
Chen et al. explored the effects of sevoflurane on CCA proliferation and apoptosis through
the Wnt/#-catenin signaling pathway. This study suggests a potential role for sevoflurane in
the treatment of CCA. The authors wrote in good English, which was easy for the readers to
understand. However, if possible, I suggest the authors to add the expression of key proteins
downstream of the Wnt/#-catenin pathway, such as GSK3#, C-Myc and CyclingD1 to enhance
the reliability of the experiment.
Please review this paper.
user
Title: Sevoflurane inhibits cholangiocarcinoma via Wnt/#-catenin Signaling pathway
Version: 1 Date: 13 Apr 2023
Reviewer's report:
Chen et al. explored the effects of sevoflurane on CCA proliferation and apoptosis through
the Wnt/#-catenin signaling pathway. This study suggests a potential role for sevoflurane in
the treatment of CCA. The authors wrote in good English, which was easy for the readers to
understand. However, if possible, I suggest the authors to add the expression of key proteins
downstream of the Wnt/#-catenin pathway, such as GSK3#, C-Myc and CyclingD1 to enhance
the reliability of the experiment.
assistant